<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001881296</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001868912</issuerCik>
      <issuerName>Enfusion, Inc.</issuerName>
      <secFileNumber>001-40949</secFileNumber>
      <issuerAddress>
        <com:street1>125 SOUTH CLARK STREET, SUITE 750</com:street1>
        <com:city>CHICAGO</com:city>
        <com:stateOrCountry>IL</com:stateOrCountry>
        <com:zipCode>60603</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(312) 253-9800</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Groman Dan</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Class A</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Fidelity Brokerage Services LLC</name>
        <address>
          <com:street1>900 Salem Street</com:street1>
          <com:city>Smithfield</com:city>
          <com:stateOrCountry>RI</com:stateOrCountry>
          <com:zipCode>02917</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>3877</noOfUnitsSold>
      <aggregateMarketValue>37451.82</aggregateMarketValue>
      <noOfUnitsOutstanding>73073502</noOfUnitsOutstanding>
      <approxSaleDate>04/17/2023</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Class A</securitiesClassTitle>
      <acquiredDate>01/10/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Vesting</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>3877</amountOfSecuritiesAcquired>
      <paymentDate>01/10/2023</paymentDate>
      <natureOfPayment>Compensation</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Daniel Groman</name>
        <address>
          <com:street1>125 South Clark Street</com:street1>
          <com:street2>Suite 750</com:street2>
          <com:city>Chicago</com:city>
          <com:stateOrCountry>IL</com:stateOrCountry>
          <com:zipCode>60603</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Class A</securitiesClassTitle>
      <saleDate>01/17/2023</saleDate>
      <amountOfSecuritiesSold>3877</amountOfSecuritiesSold>
      <grossProceeds>42375.61</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Daniel Groman</name>
        <address>
          <com:street1>125 South Clark Street, Suite 750</com:street1>
          <com:city>Chicago</com:city>
          <com:stateOrCountry>IL</com:stateOrCountry>
          <com:zipCode>60603</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Class A</securitiesClassTitle>
      <saleDate>02/17/2023</saleDate>
      <amountOfSecuritiesSold>3877</amountOfSecuritiesSold>
      <grossProceeds>44779.35</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Daniel Groman</name>
        <address>
          <com:street1>125 South Clark Street, Suite 750</com:street1>
          <com:city>Chicago</com:city>
          <com:stateOrCountry>IL</com:stateOrCountry>
          <com:zipCode>60603</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Class A</securitiesClassTitle>
      <saleDate>03/17/2023</saleDate>
      <amountOfSecuritiesSold>3877</amountOfSecuritiesSold>
      <grossProceeds>42414.38</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>04/17/2023</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>12/09/2022</planAdoptionDate>
      </planAdoptionDates>
      <signature>/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Daniel Groman</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4763}]
144
0001881296
XXXXXXXX
LIVE
0001868912
Enfusion, Inc.
001-40949
125 SOUTH CLARK STREET, SUITE 750
CHICAGO
IL
60603
(312) 253-9800
Groman Dan
Officer
Class A
Fidelity Brokerage Services LLC
900 Salem Street
Smithfield
RI
02917
3877
37451.82
73073502
04/17/2023
NYSE
Class A
01/10/2023
Restricted Stock Vesting
Issuer
N
3877
01/10/2023
Compensation
N
Daniel Groman
125 South Clark Street
Suite 750
Chicago
IL
60603
Class A
01/17/2023
3877
42375.61
Daniel Groman
125 South Clark Street, Suite 750
Chicago
IL
60603
Class A
02/17/2023
3877
44779.35
Daniel Groman
125 South Clark Street, Suite 750
Chicago
IL
60603
Class A
03/17/2023
3877
42414.38
04/17/2023
12/09/2022
/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Daniel Groman